ImpediMed Limited IPDQF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 9.91M | 9.54M | 9.18M | 8.67M | 8.23M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.91M | 9.54M | 9.18M | 8.67M | 8.23M |
| Cost of Revenue | 1.25M | 1.26M | 1.27M | 1.20M | 1.13M |
| Gross Profit | 8.66M | 8.28M | 7.91M | 7.48M | 7.10M |
| SG&A Expenses | 17.82M | 17.62M | 17.43M | 17.21M | 17.13M |
| Depreciation & Amortization | 2.86M | 2.87M | 2.88M | 2.90M | 2.95M |
| Other Operating Expenses | 2.24M | 2.05M | 1.87M | 1.83M | 1.81M |
| Total Operating Expenses | 24.31M | 23.92M | 23.55M | 23.25M | 23.12M |
| Operating Income | -14.40M | -14.38M | -14.37M | -14.57M | -14.90M |
| Income Before Tax | -16.89M | -16.28M | -15.69M | -15.30M | -15.01M |
| Income Tax Expenses | 17.70K | 18.20K | 18.70K | 17.70K | 16.80K |
| Earnings from Continuing Operations | -16.91 | -16.30 | -15.71 | -15.31 | -15.03 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.91M | -16.30M | -15.71M | -15.31M | -15.03M |
| EBIT | -14.40M | -14.38M | -14.37M | -14.57M | -14.90M |
| EBITDA | -12.75M | -12.71M | -12.69M | -12.87M | -13.15M |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 8.54B | 8.32B | 8.10B | 8.09B | 8.08B |
| Average Diluted Shares Outstanding | 8.54B | 8.32B | 8.10B | 8.09B | 8.08B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |